CompletedNot Applicable

CALLY Index and Disease Activity in Ankylosing Spondylitis

Turkey (Türkiye)65 participantsStarted 2022-01-01

Plain-language summary

This retrospective cross-sectional observational study aims to evaluate the association between the C-reactive protein-albumin-lymphocyte (CALLY) index and disease activity and functional status in patients with ankylosing spondylitis. Medical records of adult patients followed between January 1, 2022, and December 31, 2025, were reviewed. Disease activity was assessed using BASDAI and ASDAS-ESR, and functional status was evaluated using BASFI. The study investigates whether the CALLY index reflects systemic inflammatory burden beyond patient-reported disease activity

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 years and older * Diagnosis of ankylosing spondylitis according to the modified New York criteria * Availability of complete clinical and laboratory data at a single assessment time point Exclusion Criteria: * Active or chronic infection * Malignancy * Advanced hepatic or renal disease * Having conditions affecting serum albumin levels, such as nephrotic syndrome * Incomplete data

What they're measuring

BASDAI and ASDAS-ESR scores in relation to CALLY index

Timeframe: At a single assessment time point

Trial details

NCT IDNCT07509463

SponsorBursa City Hospital

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Anklyosing Spondylitis trials